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Abstract
Background: The volume effect in pancreatic surgery is well established. Regionalization to high-
volume centres has been proposed. The effect of this proposal on practice patterns is unknown.
Methods: Retrospective review of pancreatectomy patients in the Nationwide Inpatient Sample 2004–
2011. Inpatient mortality and complication rates were calculated. Patients were stratified by annual centre
pancreatic resection volume (low <5, medium 5–18, high >18). Multivariable regression model evaluated
predictors of resection at a high-volume centre.
Results: In total, 129 609 patients underwent a pancreatectomy. The crude inpatient mortality rate was
4.3%. 36.0% experienced complications. 66.5% underwent a resection at high-volume centres. In 2004,
low-, medium- and high-volume centres resected 16.3%, 24.5% and 59.2% of patients, compared with
7.6%, 19.3% and 73.1% in 2011. High-volume centres had lower mortality (P < 0.001), fewer complica-
tions (P < 0.001) and a shorter median length of stay (P < 0.001). Patients at non-high-volume centres had
more comorbidities (P = 0.001), lower rates of private insurance (P < 0.001) and more non-elective
admissions (P < 0.001).
Discussion: In spite of a shift to high-volume hospitals, a substantial cohort still receives a resection
outside of these centres. Patients receiving non-high-volume care demonstrate less favourable
comorbidities, insurance and urgency of operation. The implications are twofold: already disadvantaged
patients may not benefit from the high-volume effect; and patients predisposed to do well may contribute
to observed superior outcomes at high-volume centres.
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Introduction
Pancreatic resections are technically complex procedures with
high post-operative morbidity and mortality rates. Patient out-
comes have improved with time. Numerous studies have
addressed factors contributing to improved patient outcomes.
Pancreatic resection at a centre with a large number of similar
cases performed annually is associated with improved patient out-
comes. The myriad explanations for this difference are still being
identified. As more pancreatic resections are performed at high-
volume centres, the characteristics of patients who receive referral
to and treatment at high-volume centres are not well established.
Glasgow and Mulvihill initially described lower mortality
among pancreatic cancer patients resected at high-volume
centres, supporting regionalization of the care of these patients.1,2
The advantage of a high-volume centre resection was found to
extend to non-oncological pancreatic resections and other major
cancer surgery.3,4 For all pancreatic resections, a high-volume
centre resection is associated with shorter length of stay in addi-
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tion to improved mortality.5 These superior outcomes for a pan-
creatic resection extend to international practice settings.6–8 For
cancer care, the benefits of a high-volume centre resection include
lengthened long-term survival beyond improvements in immedi-
ate post-operative results.9–12
The factors influencing pancreatic resection outcomes are
complex and numerous. In addition to hospital volume, high
individual surgeon volume is associated with improved
mortality.13–15 Patient sociodemographic factors and comor-
bidities influence outcomes and whether potentially curative
resections are even pursued.16
This study addresses trends in hospital volume status in
a recent, national dataset of patients undergoing a pancreatic
resection. Predictors of a resection at a high-volume centre are
identified.
Patients and methods
This study is a retrospective review of data from the Nationwide
Inpatient Sample (NIS). The NIS is an administrative database
assembled by the Healthcare Cost and Utilization Project
(HCUP), part of the Agency for Healthcare Research and Quality
(AHRQ).NIS includes a sampling of nationwide short-term, non-
Federal hospitals, representing approximately 8 000 000 admis-
sions annually and 40 000 000 weighted admissions annually.17
Admission diagnosis and procedure codes from 2004 to 2011 were
queried. Admission records were included in the analysis if an
ICD-9 procedure code for a pancreatic resection was utilized.
Pancreatic resection procedures were total pancreatectomy (52.6),
radial pancreaticoduodenectomy (52.7) and partial pancreatec-
tomy (52.51, proximal pancreatectomy; 52.52, distal pancreatec-
tomy; 52.53, radical subtotal pancreatectomy; 52.59, other partial
pancreatectomy).
Patient characteristics collected included age, gender, race,
payer type and Elixhauser Total score, generated using the
HCUP Comorbidity Software, Version 3.7.18 Admission charac-
teristics collected included pancreatic diagnosis and malignancy
status, urgency of admission (elective or non-elective), year and
procedure performed, as classified above. Hospital characteristics
collected included bed size (small, medium or large), teaching
status, location (rural or urban) and region (Northeast, Midwest,
South or West). Average annual pancreatic resection volumes
were calculated for each centre. Based on categories previously
established in the literature, centres were divided into low- (less
than 5 resections annually), medium- (5 to 18 resections
annually) and high- (greater than 18 resections annually)
volume categories.19,20 A sensitivity analysis was performed to
identify very high-volume centres with cutoffs of 50, 75, 100 and
200 annual pancreatic resections. Admission outcomes collected
were inpatient mortality, length of stay and inpatient morbidity.
Morbidity was established using secondary diagnosis codes or
procedure codes and included the following categories of diag-
noses: infectious, respiratory, cardiac, wound complications,
thromboembolic, perforation and gastrointestinal bleeding or
ulceration.
All statistical analyses were performed using the design-
weighted survey procedures in SAS (version 9.3; SAS Institute,
Cary, NC, USA). For all analyses, a P-value of <0.05 was consid-
ered statistically significant. All values reported were based on
nationally weighted admissions.
Continuous variables, age and Elixhauser Total score were cat-
egorized to enhance clinical relevance. Race and payer categories
with a small number of patients were collapsed into aggregate
groups. Patient, admission and hospital characteristics by hospital
volume status were compared using the chi-square test. Mortality
and morbidity were compared by hospital volume status using the
chi-square test. Length of stay was non-normal and reported as
median with interquartile range; lengths of stay were compared by
hospital volume status using the surveyreg for sample survey data
analysis. The distribution of resections at low-, medium- and
high-volume centres over years was assessed using a Cochran–
Armitage test of trends. Sub-group analyses of mortality, compli-
cations and length of stay were performed for elective and non-
elective admissions.
A survey-weight multivariable logistic regression was per-
formed to identify predictors of resection at a high-volume
centre compared with a low- or medium-volume centre.
A univariate screen was performed using the chi-square testing.
Model building prioritized confounding over co-linearity.
Variables considered for possible inclusion in the final model
were age, gender, race, payer type, Elixhauser Total, pancreatic
diagnosis, malignancy status, urgency of admission, year,




From 2004 to 2011, 129 609 patients underwent a pancreatic
resection. A majority of patients underwent a resection at high-
volume centres (86 243, 66.5%) compared with 22.0% (28 497) at
medium-volume centres and 11.5% (14 870) at low-volume
centres. In 2004, low-,medium- and high-volume centres resected
16.3% (2101), 24.5% (3170) and 59.2% of patients (7652), com-
pared with 7.6% (1568), 19.3% (3955) and 73.1% (15 003) in
2011 (P = 0.019). The distribution of patient, admission and hos-
pital characteristics by centre resection volume are included in
Table 1.
Univariate analysis
Patients greater than or equal to 70 years of age were more
common at low-volume hospitals compared with high-volume
hospitals, but this finding was not statistically significant (4920,
33.1% versus 26 187, 30.4%; P = 0.178). Patients with Elixhauser
Totals of three or greater were less common among high-volume
compared with low-volume centres (32 103, 37.2% versus 6146,
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Table 1 Patient and hospital characteristics by resection center volume







n % n % N % n %
Patient Characteristics
Age (years) 0.178
<50 27 191 21.0% 3 107 20.9% 6 111 21.5% 17 973 20.8%
50–69 62 705 48.4% 6 843 46.0% 13 779 48.4% 42 083 48.8%
≥70 39 714 30.6% 4 920 33.1% 8 607 30.2% 26 187 30.4%
Gender 0.405
Male 63 552 49.0% 7 119 47.9% 14 085 49.4% 42 348 49.1%
Female 66 057 51.0% 7 750 52.1% 14 412 50.6% 43 895 50.9%
Race 0.018
White 81 252 62.7% 7 988 53.7% 16 679 58.5% 56 585 65.6%
Black 10 735 8.3% 1 565 10.5% 2 730 9.6% 6 439 7.5%
Hispanic 9 023 7.0% 1 421 9.6% 2 108 7.4% 5 494 6.4%
Missing 21 784 16.8% 3 081 20.7% 5 182 18.2% 13 521 15.7%
Other 6 815 5.3% 814 5.5% 1 797 6.3% 4 204 4.9%
Elixhauser Total 0.001
0 17 076 13.2% 1 945 13.1% 3 543 12.4% 11 588 13.4%
1 30 618 23.6% 3 155 21.2% 6 428 22.6% 21 035 24.4%
2 32 000 24.7% 3 624 24.4% 6 860 24.1% 21 516 25.0%
≥3 49 914 38.5% 6 146 41.3% 11 665 40.9% 32 103 37.2%
Payer <0.001
Medicare 56 187 43.4% 6 667 44.8% 12 121 42.5% 37 400 43.4%
Medicaid 9 156 7.1% 1 353 9.1% 2 332 8.2% 5 472 6.3%
Private 55 045 42.5% 5 481 36.9% 11 902 41.8% 37 663 43.7%
No charge, self-pay, other, missing 9 220 7.1% 1 369 9.2% 2 143 7.5% 5 708 6.6%
Admission and Procedure Characteristics
Malignancy Status 0.001
Benign 50 146 38.7% 6 545 44.0% 11 028 38.7% 32 573 37.8%
Malignant 79 463 61.3% 8 325 56.0% 17 468 61.3% 53 670 62.2%
Diagnosis <0.001
Malignant Pancreatic or Duodenal Neoplasm 69 023 53.3% 6 433 43.3% 14 975 52.6% 47 615 55.2%
Benign Pancreatic or Duodenal Neoplasm 15 640 12.1% 1 735 11.7% 3 565 12.5% 10 340 12.0%
Other Malignant Neoplasm 10 440 8.1% 1 891 12.7% 2 493 8.8% 6 055 7.0%
Other Benign Conditions 19 997 15.4% 3 153 21.2% 4 806 16.9% 12 038 14.0%
Pancreatic Cyst or Pseudocyst 5 430 4.2% 760 5.1% 1 271 4.5% 3 399 3.9%
Pancreatitis 9 079 7.0% 896 6.0% 1 386 4.9% 6 797 7.9%
Procedure Type <0.001
Partial Pancreatectomy 54 373 42.0% 8 881 59.7% 13 177 46.2% 32 316 37.5%
Radical Pancreaticoduodenectomy 68 094 52.5% 5 342 35.9% 14 207 49.9% 48 546 56.3%
Total Pancreatectomy 7 141 5.5% 647 4.4% 1 113 3.9% 5 381 6.2%
Elective Status <0.001
Non-Elective 28 826 22.2% 5 779 38.9% 7 771 27.3% 15 275 17.7%
Elective 100 783 77.8% 9 090 61.1% 20 725 72.7% 70 967 82.3%
Year 0.019
2004 12 924 10.0% 2 101 14.1% 3 170 11.1% 7 652 8.9%
2005 12 342 9.5% 1 955 13.1% 3 149 11.1% 7 238 8.4%
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41.3%, P = 0.001). Patients of white race were more common at
high-volume centres compared with low-volume centres (56 585,
65.6% versus 7988, 53.7%, P = 0.018). A private payment source
was less common at low-volume centres compared with high-
volume centres (5481, 36.9% versus 37 663, 43.7%; P < 0.001).
These demographic disparities persist when examining very high-
volume centres.
Resections at high-volume centres were more often performed
for malignant conditions than at low-volume centres (53 670,
62.2% versus 8325, 56.0%; P = 0.001). The majority of resections
at high-volume centres were radical pancreaticoduodenectomies
(48 546, 56.3%) whereas the majority of resections at low-volume
centres were partial pancreatectomies (8881, 59.7%; P < 0.001). A
larger percentage of low-volume resections occurred during non-
elective admissions (5779, 38.9% versus 15 275 17.7%; <0.001).
For very high-volume centres, the percentage of resections that
occurred during non-elective admissions were 16.2%, 12.6%,
11.6% and 8.5%, respectively, for centres with annual volumes of
greater than or equal to 50, 75, 100 and 200. High-volume centre
resections were largely performed at urban (84 988, 98.6%) and
teaching (82 821, 96.0%) facilities with a large bed size (77 873,
90.3%).
Patient outcomes
The overall mortality rate was 4.3% (5603). Those resected at
high-volume centres experienced lower mortality rates (P <
0.001), lower complication rates (P < 0.001) and shorter median
lengths of stay (P < 0.001) as displayed in Table 2. Among patients
resected during non-elective admissions, mortality rates were
12.8% (740) at low-volume centres compared with 6.8% (1031) at
high-volume centres (P < 0.001). Complication rates were 57.1%
(3298) at low-volume centres compared with 47.5% (7259) at
high-volume centres. Outcomes for resections performed during
elective and non-elective admissions are displayed in Fig. 1.
Mortality and complication rates among patients resected a
very high-volume centres decreased as the volume threshold
increased. At centres performing 50 or more resections annually,
complication and mortality rates were 31.6% (18 591) and 2.8%
(1634) compared with 39.7% (28 068) and 5.6% (3969) at other
centres (both P < 0.001). At centres performing 75 or more resec-
tions annually, complication and mortality rates were 30.0%
(11 124) and 2.7% (999) compared with 38.4% (35 535) and 5.0%
(4604) at other centres (both P < 0.001). At centres performing
100 or more resections annually, complication and mortality rates
were 29.4% (7763) and 2.5% (649) compared with 37.7%
Table 1 Continued







n % n % N % n %
2006 12 578 9.7% 1 941 13.1% 3 249 11.4% 7 389 8.6%
2007 14 727 11.4% 1 990 13.4% 3 049 10.7% 9 689 11.2%
2008 18 724 14.4% 2 110 14.2% 4 237 14.9% 12 377 14.4%
2009 16 031 12.4% 1 655 11.1% 3 168 11.1% 11 208 13.0%
2010 21 757 16.8% 1 549 10.4% 4 519 15.9% 15 688 18.2%
2011 20 525 15.8% 1 568 10.5% 3 955 13.9% 15 003 17.4%
Hospital Characteristics
Hospital Location 0.002
Rural 3 095 2.4% 1 411 9.5% 430 1.5% 1 255 1.5%




Non-teaching 22 904 17.7% 9 844 66.2% 9 638 33.8% 3 422 4.0%
Teaching 106 705 82.3% 5 025 33.8% 18 859 66.2% 82 821 96.0%
Hospital Region 0.191
Northeast 26 769 20.7% 2 611 17.6% 4 389 15.4% 19 769 22.9%
Midwest 29 838 23.0% 3 582 24.1% 6 042 21.2% 20 215 23.4%
South 45 212 34.9% 5 396 36.3% 9 535 33.5% 30 281 35.1%
West 27 790 21.4% 3 281 22.1% 8 530 29.9% 15 978 18.5%
Hospital Bed Size <0.001
Small 7 019 5.4% 2 133 14.3% 2 275 8.0% 2 611 3.0%
Medium 18 121 14.0% 5 296 35.6% 7 066 24.8% 5 759 6.7%
Large 104 469 80.6% 7 440 50.0% 19 156 67.2% 77 873 90.3%
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(38 896) and 4.8% (4954) at other centres (both P < 0.001). At
centres performing 200 or more resections annually, complication
and mortality rates were 26.9% (3709) and 2.1% (288) compared
with 37.1% (42 950) and 4.6% (5315) at other centres (complica-
tions P = 0.001, mortality P < 0.001).
Multivariate analysis
Themultivariable logistic regressionmodel predicting resection at
a high-volume centre compared with a low- or medium-volume
centre included age, gender, race, Elixhauser Total, payer, urgency
of admission, diagnosis and procedure type. Unadjusted and
adjusted odds ratios (ORs) for the predictors are in Table 3 and
Fig. 2. After adjustment, statistically significant predictors were
Elixhauser Total of three or greater [OR 0.796, confidence interval
(CI) 0.673–0.942], non-elective admission (OR 0.497, CI 0.393–
0.629), radical pancreaticoduodenectomy (OR 1.666, CI 1.511–
1.837), total pancreatectomy (OR 2.105, CI 1.688–2.625), non-
pancreatic and non-duodenal malignant neoplasm (OR 0.832, CI
0.730–0.949), pancreatitis (OR 1.622, CI 1.289–2.039), black race
(OR 0.758, CI 0.604–0.952), age 50–69 (OR 0.874, CI 0.805–
0.950) and age 70 or greater (OR 0.811, CI 0.717–0.916).
Discussion
This study examined trends in high-volume centre pancreatic
resections nationally from 2004 to 2011. Patients resected at high-
volume centres experienced less morbidity and mortality as well
as shorter median length of stay. Morbidity and mortality rates
were lower at very high volume centres, with rates decreasing as
the annual volume threshold increased. Over time, an increasing
percentage of patients were resected at high-volume centres. There
remain demographic discrepancies between patients undergoing a
resection at high-volume centres compared with low- or medium-
volume centres. After adjustment, predictors of not undergoing a
resection at a high-volume centre were Elixhauser Total of three or
greater, non-elective admission status, resection for a non-
pancreatic and non-duodenal malignant neoplasm, black race and
age over 50 years, suggesting that patients who are predisposed to
Table 2 Patient outcomes by resection centre volume







Number 129 609 14 870 28 497 86 243
Percentage of Total – 11.5% 22.0% 66.5%
Mortality Rate (%) 4.3% 8.1% 5.9% 3.1% <0.001
Median Length of Stay [Q1,Q3] 10 [7,16] 12 [7,19] 11 [7,19] 9 [7,15] <0.001
Complication Rate (%) 36.0% 45.8% 39.7% 33.1% <0.001
Figure 1 Patient outcomes performed during elective and non-elective admissions by pancreatectomy centre volume
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poor outcomes are undergoing a resection at lower volume
centres.
Although resection at high-volume hospitals has an established
association with improved patient outcomes, who receives referral
to these centres and why remains less well explained. Patients
undergoing complex oncological resections at low-volume centres
are more likely to be non-white, without private insurance, under-
going emergent admission and have a high number of
comorbidities.21–24 Those who undergo a high-volume centre
resection have lower mortality rates and shorter length of stay.1–5
Even in locations with multiple high-volume centres, such as New
York City, non-white patients are still more likely to receive a
resection at a low-volume centre.25 When a resection occurs at a
rural hospital for select high-risk operations, it is unlikely to occur
Table 3 Logistic regression model assessing predictors of pancreatectomy at a high-volume centre (> 18 per year)
Unadjusted Adjusted
Odds ratio 95% Confidence limits Odds ratio 95% Confidence limits
Elixhauser Total
0 ——Ref—— ——Ref——
1 1.040 0.935 1.156 0.965 0.870 1.070
2 0.972 0.866 1.091 0.903 0.802 1.017
≥3 0.854 0.732 0.995 0.796 0.673 0.942
Payer
Medicaid 0.685 0.547 0.860 0.840 0.668 1.055
Medicare 0.919 0.847 0.997 0.984 0.889 1.088
Private ——Ref—— ——Ref——
No charge, self-pay, other, missing 0.750 0.572 0.984 0.897 0.692 1.163
Elective Status
Non-Elective 0.474 0.377 0.595 0.497 0.393 0.629
Elective ——Ref—— ——Ref——
Procedure Type
Partial Pancreatectomy ——Ref—— ——Ref——
Radical Pancreaticoduodenectomy 1.695 1.550 1.853 1.666 1.511 1.837
Total Pancreatectomy 2.086 1.639 2.655 2.105 1.688 2.625
Diagnosis
Malignant Pancreatic or Duodenal Neoplasm ——Ref—— ——Ref——
Benign Pancreatic or Duodenal Neoplasm 0.877 0.778 0.988 0.952 0.836 1.084
Nonpancreatic Malignant Neoplasm 0.621 0.542 0.711 0.832 0.730 0.949
Other Benign Conditions 0.680 0.596 0.776 0.927 0.811 1.060
Pancreatic Cyst or Pseudocyst 0.752 0.630 0.898 0.942 0.779 1.139
Pancreatitis 1.339 1.048 1.710 1.622 1.289 2.039
Race
White ——Ref—— ——Ref——
Black 0.653 0.520 0.821 0.758 0.604 0.952
Hispanic 0.679 0.462 0.998 0.755 0.514 1.109
Missing 0.713 0.431 1.181 0.710 0.431 1.169
Other 0.702 0.518 0.951 0.758 0.558 1.028
Gender
Female ——Ref—— ——Ref——
Male 1.008 0.954 1.066 0.993 0.939 1.049
Age (years)
<50 ——Ref—— ——Ref——
50–69 1.047 0.952 1.151 0.874 0.805 0.950
≥70 0.993 0.875 1.127 0.811 0.717 0.916
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at a high-volume centre, suggesting a further need for
regionalization of complex procedures.26 This regionalization for
rural patients undergoing a pancreatic resection would often
increase patient travel time.27
Findings from this study are consistent with earlier publica-
tions. The vast majority of resections occurred in high-volume
centres, suggesting that regionalization has been widely accepted
and most patients are benefiting from the volume effect. However,
in spite of this progress there are still significant disparities in
which patients undergo a resection at high-volume centres and
benefit from the volume effect.
The utilization of the NIS, an administrative database, creates
several limitations for this analysis. Clinical details that may influ-
ence patient outcomes or reasons for referral are not available.
Similarly, limited information about the individual patients pre-
vents analysis of long-term outcomes or geographical factors that
may influence referral to high-volume centres. Because of the
large population analyzed, small differences in patient character-
istics and outcomes may be statistically significant, but not clini-
cally meaningful.
In spite of these limitations, this study identifies unequal refer-
rals to high-volume centres even in the setting of widespread
regionalization. Those patients who are not receiving care at high-
volume centres do not benefit from the improved outcomes owing
to surgeon experience, established care pathways, and hospital
staffing and infrastructure to support frequent complex surgical
procedures. Low-volume centres resect a disproportionately large
number of patients who fall into groups with historically worse
post-operative outcomes at baseline. A portion of the superior
outcomes found at high-volume centres may be because of selec-
tive referral of patients who are predisposed to do well, whereas
those patients who are less desirable surgical candidates remain at
local, low-volume centres for resection.
Research regarding patterns of regionalization is necessary to
further understand why some patient populations do not receive
the benefit of a resection at a high-volume centre. Understanding
geographical and referral network barriers will allow surgeons,
and referring physicians, to identify patients who may not already
seek pancreatic surgery at high-volume centres.
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